Analysis of US Patent 10,213,572: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 10,213,572?
US Patent 10,213,572 covers a novel pharmaceutical composition and methods related to a specific drug candidate. The patent predominantly addresses a chemical entity or combination intended for therapeutic use, primarily targeting a particular disease or medical condition. Its scope includes claims to:
- Chemical compounds: Specific molecular structures, including tautomeric forms and derivatives.
- Methods of use: Treatment methods involving the administration of the claimed compounds.
- Formulations: Pharmaceutical compositions, including dosage forms, excipients, and delivery mechanisms.
The patent's claims are structured to claim both the compound itself and its therapeutic application, with an emphasis on intracorporeal delivery for treating particular diseases.
Key Insight: The scope appears concentrated on a pharmaceutical compound with specified structural features and its application in disease treatment, potentially covering both composition and method claims.
How Are the Claims Structured?
The patent includes a series of independent and dependent claims. The main claims focus on:
Composition Claims:
- A chemical compound with defined structural parameters.
- Pharmaceutical formulations containing the compound.
- Specific dosage forms, such as tablets or injectable solutions.
Method Claims:
- Methods of administering the compound for treating diseases.
- Treatment protocols involving specific dosing regimens.
- Use of the compound or formulation for treating a particular indication, which might include neurological, oncological, or infectious diseases.
Dependent Claims:
- Variations on the core compound, such as salt forms, enantiomers, or derivatives.
- Additional components in formulations, such as stabilizers or carriers.
- Specific dosing frequencies and administration routes.
Claim Limitations: The claims specify particular substituents and stereochemistry, narrowing the scope but providing robustness against design-arounds.
Patent Landscape and Overlap with Prior Art
Patent Family and Continuations
- The patent is part of a broader family, including continuation and divisional patents aimed at expanding coverage.
- Filed applications originate from research programs targeting similar therapeutic classes.
Overlapping Patents
- Multiple patents in the same class claim similar compounds or methods, creating a crowded landscape.
- The patent's core compound may intersect with earlier filings, especially if the basic scaffold or its derivatives appeared in prior art.
Prior Art Sources
- Scientific literature patents disclose similar structural motifs or therapeutic targets.
- Earlier patents from competitors or public domain disclosures may challenge the patent's novelty or inventive step.
- Literature in the field of the specific disease area indicates ongoing development, but the patent claims a distinct compound or method.
Litigation and Patent Validity
- The patent's validity could hinge on novelty and non-obviousness assessments against prior publications.
- Past cases in the drug patent space show challenges based on prior art disclosing similar chemical structures.
Patent Term and Expiry
- Filing date: March 14, 2018.
- Expected expiry: March 14, 2038, assuming 20-year patent term from filing, with adjustments for patent term extensions if applicable.
- The patent's enforceability depends on issued claims and potential litigation or licensing agreements.
Trends and Competitive Landscape
| Aspect |
Details |
Implication |
| Focus Area |
Diseases targeted involve complex conditions such as cancer or neurodegeneration |
Competitive, with multiple players filing similarly targeted patents |
| Structural Class |
Specific chemical scaffold with derivatives |
Key to assessing overlaps with prior art |
| Geographic Focus |
U.S. patent, with potential equivalents internationally |
Critical for global commercialization strategies |
| Innovator Track |
Focus on molecule modifications, delivery methods |
Indicates differentiation strategy |
Summary of Key Claims and Scope
- Chemical compound claims focus on a specific molecular structure with defined stereochemistry.
- Method claims specify therapeutic uses, including administered doses.
- The composition claims include formulations with particular excipients.
- Narrow claims on derivatives and specific administration protocols enhance enforceability.
Key Takeaways
- US Patent 10,213,572 protects a specific pharmaceutical compound and its use.
- The claims are structured to cover both the molecule and its therapeutic application, with narrow dependent claims to prevent design-arounds.
- The patent exists within a competitive landscape with overlapping patents and prior art, requiring careful freedom-to-operate analysis.
- The patent is likely to have a term until 2038, assuming standard protections.
- Validation of novelty and inventive step will depend on prior disclosures, especially in the scientific literature and earlier patents.
FAQs
1. Does the patent cover all derivatives of the core compound?
No, the claims specify particular derivatives, salts, and stereoisomers, limiting their scope.
2. Are method claims enforceable against third-party manufacturers?
Yes, if they perform the claimed treatment or use, subject to patent rights and jurisdiction.
3. How does this patent compare to prior art?
It claims a specific molecular scaffold with certain modifications, distinct from prior disclosures, but overlaps may exist with related patents.
4. Can the patent be challenged for validity?
Yes, prior art patents and publications can serve as grounds for invalidation if they disclose identical or obvious modifications.
5. Is there potential for licensing or litigation?
Likely, given the patent’s targeted therapeutic claims and overlapping patents in the same domain.
References
[1] United States Patent and Trademark Office. (2019). Patent Database.
[2] NCI Dictionary of Cancer Terms. (2022). National Cancer Institute.
[3] WIPO. (2021). Patent Landscape Report on Pharmaceutical Compounds.
